Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands.

Benchmark Animal Health Ltd., a subsidiary of Benchmark Holdings Plc, is a company headquartered in Sheffield, UK. The firm provides veterinary services. It was founded in 2014.\nThe company says this about itself: The company is engaged in the supply of health products and solutions to the livestock. companion animal and aquaculture sectors.

Norimun AS develops IgY antibodies for passive immunization in aquaculture and livestock markets. The company is headquartered in Akershus, Norway.

Mowi, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. Mowi is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. Mowi also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Pieters, The Irish Organic Salmon Company, Rebel Fish, Sterling, Olav's, Supreme Salmon, Ducktrap River, Kritsen, Donegal Silver, Harbour Salmon, Appeti’Marine, Mowi, Laschinger, and Admiral's brands. Marine Harvest that began operation in 1965 became Mowi in December 2018. It has its headquarters in 1965, with its headquarters in Bergen in Norway.

Nippon Suisan produces and distributes seafood products. It offers fresh and frozen fish and other fish products including fish oil. It is a subsidiary of Nippon Suisan Kaisha Ltd. The company is headquartered in Tokyo, Japan.

PHARMAQ is the world's leading pharmaceutical company supplying the aquaculture industry and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. The vaccines are manufactured in a state of the art production facility in Overhalla and Oslo, Norway. Administration and research and development activities are based in Oslo with subsidiaries in Norway, Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 200 employees. The company's products are marketed in Europe, North and South America, and Asia. Rapid growth and development of a global aquaculture industry creates challenges and the need for continuous improvement. PHARMAQ's willingness to change nurtures flexibility and motivation - for the benefit of all. PHARMAQ`s vaccines are manufactured in a state-of-the-art production facility in Overhalla, Norway. Administration and Research and Development activities are based in Oslo, Norway. With subsidiaries in Chile, United Kingdom, Vietnam and Turkey, PHARMAQ has around 165 employees. PHARMAQ products are marketed in Europe, North and South America and Asia through an extensive network of distributors and wholesalers.

Interway International Ltd. is a private company headquartered in Hong Kong, Hong Kong, that manufactures and distributes chemicals. Sufan Siauw is the current CEO of the firm.

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Foster-Miller, Inc., a wholly owned subsidiary of Qinetiq, is a United States-based military robotics manufacturer. Its two best-known products are its TALON robots and its LAST Armor. Founded and based in Waltham, Massachusetts, it has offices in Albany, New York, Washington, D.C., and near Boston. Foster-Miller became a wholly owned Independent subsidiary of Qinetiq in 2004. Its parent has signed a special security agreement, allowing it to work independently in sensitive projects for US defense.

Kyoritsu Seiyaku Corp. engages in the research, development, and production of vaccines and drugs for pets, livestock, and marine animals. It also deals with the manufacture of industrial and general deodorizers. The company was founded on May 19, 1955 and is headquartered in Tokyo, Japan.

Seacalx AS develops medicinal products for treatment of sea lice. Its product Qlice is used for de-licing of salmon. The firm intends to develop and sell pharmaceuticals via veterinarians to target the fish farming market. The company was founded in 2012 and is headquartered in Bergen, Norway.

Schweitzer SA manufactures and supplies carpentry and metal locks. The company was founded in 1973 and is headquartered in Bindernheim, France.

Google X, stylized as Google[x], is a semi-secret facility run by [Google](http://crunchbase.com/organization/google) located about a half mile from the corporate headquarters Googleplex in Mountain View, California. Work at the lab is overseen by [Sergey Brin](http://crunchbase.com/person/sergey-brin), one of Google's co-founders, and by scientist and entrepreneur [Astro Teller](http://crunchbase.com/person/astro-teller). Teller says that they aim to improve technologies by a factor of 10, and to develop "science fiction-sounding solutions." Projects include Project Glass, the Google driveless car, Project Loon, and Google Contact Lens. Source: [Wikipedia](http://en.wikipedia.org/wiki/Google_X)

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform.\nThe company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil.\nThe firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits.\nFocusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner.\nBuilding technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins.\nOpenness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates.\nCost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

DaebongLS Co., Ltd. engages in the manufacturing and distributing of raw materials for pharmaceuticals and cosmetics. It operates through the following business divisions: Cosmetics, Pharmaceuticals, and Food Additives. The Cosmetics division supplies conditioners, emollients, emulsifiers, permanent wave, and solubilizers. The Pharmaceuticals division offers raw materials used to prevent seizures, peptic ulcer, and hypertension. The Food Additives division provides aquacals, ascorbic acids, corn starches, fish, and folic oils. The company was founded by Jong-Ho Park on July 8, 1986 and is headquartered in Incheon, South Korea.